Sorrento Therapeutics Inc (SRNE)
0.024
0.00 (0.00%)
USD |
OTCM |
Apr 18, 15:52
Sorrento Therapeutics Net Income (TTM): -548.10M for June 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -548.10M |
| March 31, 2023 | -671.64M |
| December 31, 2022 | -572.84M |
| September 30, 2022 | -493.57M |
| June 30, 2022 | -523.79M |
| March 31, 2022 | -471.65M |
| December 31, 2021 | -428.32M |
| September 30, 2021 | -355.41M |
| June 30, 2021 | -319.63M |
| March 31, 2021 | -230.76M |
| December 31, 2020 | -298.46M |
| September 30, 2020 | -289.78M |
| June 30, 2020 | -270.17M |
| March 31, 2020 | -249.19M |
| December 31, 2019 | -292.07M |
| September 30, 2019 | -279.02M |
| June 30, 2019 | -261.94M |
| March 31, 2019 | -279.04M |
| December 31, 2018 | -203.54M |
| September 30, 2018 | -105.32M |
| June 30, 2018 | -60.05M |
| March 31, 2018 | -0.377M |
| December 31, 2017 | 9.133M |
| September 30, 2017 | -57.17M |
| June 30, 2017 | -39.22M |
| Date | Value |
|---|---|
| March 31, 2017 | -68.34M |
| December 31, 2016 | -60.92M |
| September 30, 2016 | -66.54M |
| June 30, 2016 | -83.37M |
| March 31, 2016 | -51.02M |
| December 31, 2015 | -45.81M |
| September 30, 2015 | -30.84M |
| June 30, 2015 | -37.51M |
| March 31, 2015 | -35.00M |
| December 31, 2014 | -34.66M |
| September 30, 2014 | -37.45M |
| June 30, 2014 | -33.20M |
| March 31, 2014 | -29.48M |
| December 31, 2013 | -21.91M |
| September 30, 2013 | -12.37M |
| June 30, 2013 | -10.25M |
| March 31, 2013 | -6.461M |
| December 31, 2012 | -4.845M |
| September 30, 2012 | -3.853M |
| June 30, 2012 | -3.314M |
| March 31, 2012 | -3.458M |
| December 31, 2011 | -3.236M |
| September 30, 2011 | -2.662M |
| June 30, 2011 | -2.405M |
| March 31, 2011 | -1.893M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-671.64M
Minimum
Mar 2023
-230.76M
Maximum
Mar 2021
-385.67M
Average
-319.63M
Median
Jun 2021
Net Income (TTM) Benchmarks
| Scilex Holding Co | -114.33M |
| AIM ImmunoTech Inc | -28.96M |
| Perspective Therapeutics Inc | -46.51M |
| Protalix BioTherapeutics Inc | 8.312M |
| Armata Pharmaceuticals Inc | -69.04M |